MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Predictors of different progressive trajectories of cognition in Parkinson’s disease

G. Smith, R. Zielinski, C. Venuto, M. Javidnia, K. Kieburtz (Rochester, NY, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 439

Keywords: Cognitive dysfunction, Parkinsonism

Category: Parkinson's Disease: Cognitive functions

Objective: To identify subgroups of people living with Parkinson’s disease (PD) who have statistically distinct trajectories of Montreal Cognitive Assessment (MoCA) scores over four years, and to explore baseline features predictive of MoCA progression trajectories.

Background: Cognitive decline is one of the most common and detrimental non-motor symptoms in PD. Predicting progression of cognitive changes in PD remains an active area of research.

Method: Longitudinal data came from the Parkinson’s Progression Markers Initiative early de novo PD cohort. Latent class mixed modeling (LCMM) was used to identify PD progression subgroups demonstrating distinct patterns of MoCA scores over four years. We considered models with one to six latent classes (i.e., subgroups) and selected the model that provided the best fit to the data according to minimization of the Bayesian Information Criterion. We then trained a Random Forest (RF) classifier to predict subgroup classifications assigned by the LCMM. The data features were ranked by predictive power based on RF feature importance, and reduced RF models were then trained iteratively using the top one to 162 features.

Results: 413 participants with early PD were included. A three-class model was chosen to describe MoCA scores over 4 years. The three classes were categorized as rapid (mean rate of progression: -4 points/year), moderate (-1 point/year) and stable (-0.05 points/year) progression trajectories, and included 1%, 13%, and 86% of the cohort, respectively. Due to the low number of individuals in the rapid trajectory class, RF models were trained to predict either progressive (rapid or moderate) or stable trajectories. Model accuracy reached 93.7% using 162 different features, and 92.2% using the top 10 features. Compared to the stable trajectory group, those in the progressive group were older, reported more constipation problems, and performed worse on different measures of cognitive domains including memory, executive, and processing speed at baseline.

Conclusion: We identified distinct subgroups of cognition changes over 4 years and their predictors. Next steps include validation of subgroups and predictors on external data.

To cite this abstract in AMA style:

G. Smith, R. Zielinski, C. Venuto, M. Javidnia, K. Kieburtz. Predictors of different progressive trajectories of cognition in Parkinson’s disease [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/predictors-of-different-progressive-trajectories-of-cognition-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/predictors-of-different-progressive-trajectories-of-cognition-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley